What Is Competitive Inhibition Mechanism and Lineweaver Burk Graph
The inhibition that is caused due to the impact of drugs and enzymes can be irreversible or reversible in nature. In the case of reversible inhibition, a state of equilibrium is easily established between the inhibitory drug and the enzyme. The irreversible inhibitions can be grouped into three types and these are known as competitive inhibition, uncompetitive inhibition, and non-competitive inhibition.
(Image will be uploaded soon)
In the case of competitive inhibition, the drug will act as the mimic of the normal substrate and will compete against the actual substrate for the activated enzyme site. It is important for the concentration effects to exist in the case of competitive inhibition. In this article, students will learn more about competitive inhibition and see the competitive inhibition example.
What are Reversible Inhibitors?
A reversible inhibitor results in the inactivation of a particular enzyme through certain noncovalent and reversed interactions. Unlike the irreversible inhibitors, the reversible ones can easily dissociate from the enzymes. Noncompetitive inhibition and competitive inhibition of enzymes are common examples of reversible inhibition. There is a third kind which is known as uncompetitive inhibition.
Competitive Inhibition Definition and Process
One of the easiest types of inhibition in enzymes would be competitive inhibition. It is the one that is most commonly used in the pharmaceutical industry. There are certain molecules that tend to act as competitive inhibitors of the enzyme. These molecules basically resemble the normal substrates that take place in the enzyme. A main competitive inhibition example can be seen in the case of methotrexate. This inhibitor resembles the appearance of the folate substrate that is present in the enzyme dihydrofolate reductase or DHFR. This is the enzyme responsible for the catalyzing action seen in the reduction reaction of folate which results in the creation of nucleotides.
With the presence of methotrexate, some particles of the enzyme will bind themselves to the methotrexate instead of binding to the folate that is present in the enzyme. Hence, for the time period during which the methotrexate is bound, the enzyme will remain inactive and hence will not be able to bind with the folate. Hence, the enzyme remains in an inhibited stage. It is important to note that the binding site of DHFR with the methotrexate is the active binding site. This is the same place where the binding with the folate should take place. Hence, the methotrexate parties compete with the folate for the enzyme binding process. With more quantities of methotrexate, the folate doesn’t have an active role to play in the enzyme.
Non-Competitive Inhibition Definition and Process
In order to understand the difference between competitive and noncompetitive inhibition, one needs to know what the latter is in the first place. In this type of enzyme inhibition, the inhibitors that don’t have a resemblance with the substrate are involved in the process. One important thing in this type of inhibition is that the binding doesn’t necessarily occur in the active site. There is a separate site present in the enzyme where the binding occurs. The effect that is produced due to the binding of a non-competitive inhibitor to the enzyme is pretty different when compared to the competitive inhibitor. This difference occurs since there is no competition for the binding.
(Image will be uploaded soon)
In the case of competitive inhibition, it is possible to reduce the effect of the inhibitor by increasing the amount of substrate in the enzyme. However, in the case of non-competitive inhibition, such inclusion will not make a difference. This means that even if the amount of the substrate in the enzyme is increased, there will be no effect on the percentage of the active enzyme. Hence, the percentage remains the same in all ranges.
Noncompetitive inhibition actually causes the reduction of the enzyme amount with the fixed amount of substrate concentration. One of the most common examples of such a type of inhibition is seen in feedback inhibition. This is one of the common biochemical processes that tend to use non-competitive inhibitors in order to control the enzymatic activity. This process is extremely useful in the synthesis of different amino acids.
By studying the enzyme inhibition, students can learn more about the different types of inhibition processes. In the case of competitive inhibition, the inhibitor and the substrate will compete for the binding site. In the case of non-competitive inhibition, the inhibitor as well as the substrate bind in different binding sites. In the case of uncompetitive inhibition, the inhibitor will bind to the enzyme-substrate complex.
FAQs on Competitive Inhibition in Enzyme Activity Explained
1. What is competitive inhibition in biology?
Competitive inhibition is a type of enzyme inhibition in which a molecule similar to the substrate competes for binding at the active site of an enzyme.
- The inhibitor resembles the normal substrate in structure.
- It binds reversibly to the enzyme’s active site.
- This prevents the substrate from binding and forming the enzyme–substrate complex.
- Its effect can be reduced by increasing substrate concentration.
2. How does competitive inhibition work?
Competitive inhibition works by allowing a structurally similar molecule to compete with the substrate for the enzyme’s active site.
- The competitive inhibitor binds to the active site instead of the substrate.
- No product is formed while the inhibitor is bound.
- The binding is usually reversible.
- Increasing substrate concentration can outcompete the inhibitor.
3. What happens to Vmax and Km in competitive inhibition?
In competitive inhibition, Vmax remains unchanged while Km increases.
- Vmax stays the same because adding more substrate can overcome inhibition.
- Km increases because a higher substrate concentration is required to reach half of Vmax.
- This indicates a decreased apparent affinity between enzyme and substrate.
4. What is an example of competitive inhibition?
A classic example of competitive inhibition is the inhibition of succinate dehydrogenase by malonate.
- Malonate resembles the substrate succinate.
- It binds to the enzyme’s active site.
- It prevents succinate from binding and being converted in the Krebs cycle.
5. How is competitive inhibition different from noncompetitive inhibition?
Competitive inhibition involves binding at the active site, whereas noncompetitive inhibition occurs at a different site on the enzyme.
- Competitive inhibitors bind to the active site.
- Noncompetitive inhibitors bind to an allosteric site.
- Competitive inhibition increases Km but does not change Vmax.
- Noncompetitive inhibition decreases Vmax but does not change Km.
6. Why can competitive inhibition be overcome by increasing substrate concentration?
Competitive inhibition can be overcome because substrate molecules can outcompete the inhibitor for the active site when present in high concentration.
- Both substrate and inhibitor compete for the same binding site.
- Higher substrate levels increase the chance of substrate binding.
- At very high substrate concentration, the enzyme reaches normal Vmax.
7. Is competitive inhibition reversible or irreversible?
Competitive inhibition is typically reversible because the inhibitor binds non-covalently to the enzyme.
- The inhibitor attaches through weak interactions such as hydrogen bonds or ionic bonds.
- It can dissociate from the active site.
- Normal enzyme function returns when the inhibitor is removed.
8. What is the role of the active site in competitive inhibition?
The active site is the region of the enzyme where both the substrate and competitive inhibitor bind.
- It has a specific shape complementary to the substrate.
- Competitive inhibitors mimic the substrate’s structure.
- Only one molecule (substrate or inhibitor) can occupy it at a time.
9. How is competitive inhibition important in medicine?
Competitive inhibition is important in medicine because many drugs act as competitive inhibitors of specific enzymes.
- Sulfonamides inhibit bacterial folic acid synthesis.
- Methotrexate competitively inhibits dihydrofolate reductase in cancer therapy.
- Statins inhibit cholesterol synthesis.
10. What is the effect of competitive inhibition on enzyme-substrate complex formation?
Competitive inhibition reduces the formation of the enzyme–substrate complex by blocking the active site.
- The inhibitor binds to the enzyme first.
- The substrate cannot bind while the inhibitor occupies the site.
- This decreases the number of productive enzyme–substrate interactions.
